The binding properties of two antitumor ruthenium(III) complexes to apotransferrin.
暂无分享,去创建一个
[1] F. Kratz,et al. Spectral characterization of ruthenium (III) transferrin. , 1993, Journal of inorganic biochemistry.
[2] R. Crichton,et al. Iron metabolism--new perspectives in view. , 1992, Biochemistry.
[3] E. Baker,et al. New perspectives on the structure and function of transferrins. , 1992, Journal of inorganic biochemistry.
[4] D. Neville,et al. Uptake and concentration of bioactive macromolecules by K562 cells via the transferrin cycle utilizing an acid-labile transferrin conjugate. , 1991, The Journal of biological chemistry.
[5] M. Cazzola,et al. Manipulations of cellular iron metabolism for modulating normal and malignant cell proliferation: achievements and prospects. , 1990, Blood.
[6] Edward N. Baker,et al. Apolactoferrin structure demonstrates ligand-induced conformational change in transferrins , 1990, Nature.
[7] S. Pizzo,et al. Selectivity and stereospecificity of the reactions of dichlorodiammineplatinum(II) with three purified plasma proteins. , 1988, Journal of inorganic biochemistry.
[8] H. Schugar,et al. Detailed correlations between the ligand-to-metal charge-transfer (LMCT) spectra of copper(II) and ruthenium(III) imidazoles and imidazolates. Electronic structures of carbon-bound ruthenium(III) imidazoles and imidazolates , 1984 .
[9] W Wolf,et al. Preparation and metabolism of a cisplatin/serum protein complex. , 1980, Chemico-biological interactions.
[10] M. Schlabach,et al. The nonspecific binding of Fe3+ to transferrin in the absence of synergistic anions. , 1975, The Journal of biological chemistry.
[11] P. Manoharan,et al. Optical and magnetic properties and geometry of some d5 ruthenium complexes , 1973 .
[12] M. Henn,et al. New Ruthenium Complexes for the Treatment of Cancer , 1989 .
[13] K. Takahashi,et al. Antitumor activity and toxicity of serum protein-bound platinum formed from cisplatin. , 1985, Japanese journal of cancer research : Gann.